We are analyzing https://link.springer.com/article/10.1007/bf02172032.

Title:
Interleukin-1β-converting enzyme and related proteases as potential targets in inflammation and apoptosis | Perspectives in Drug Discovery and Design
Description:
Interleukin-1β-converting enzyme (ICE, EC 3.4.22.36) is the cysteine protease responsible for the production of interleukin-1β in monocytes. Since its discovery in 1989, this enzyme has been the subject of enthusiastic investigation because of the suspected role of this cytokine in the pathogenesis of inflammatory diseases such as rheumatoid arthritis. These studies have culminated in the purification and cloning of the enzyme, development of potent inhibitors, determination of its structure by X-ray crystallography and the development of knockout mice, which have confirmed an important role for this protease in inflammation. Late in 1993, the protease became the subject of further interest because of its homology to CED-3, the product of a gene required for programmed cell death in the nematodeC. elegans. It is now clear that ICE is the first identified member of a new cysteine protease family that includes CED-3 and at least four other human homologues. Although the extent to which ICE itself plays a role in mammalian apoptosis remains controversial, it is clear that at least one of these homologues, CPP32, is an important player. The recognition that members of this family play key biological roles in both inflammation and apoptosis, two extremely attractive targets for therapeutic intervention, has led to intense interest in these proteases.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Social Networks

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 8,170,536 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

google, scholar, chem, miller, thornberry, med, article, cell, chapman, lett, nature, biol, enzyme, inflammation, schmidt, kostura, howard, research, apoptosis, immunol, limjuco, biochemistry, helaszek, ator, bioorg, privacy, cookies, content, proteases, nicholson, access, usa, kronheim, black, ding, yamin, graybill, dolle, yuan, publish, search, perspectives, discovery, interleukinβconverting, related, protease, role, sci, exp, science,

Topics {✒️}

interleukin-1β-converting enzyme il-1β cleavage detection month download article/chapter related subjects interleukin-1β privacy choices/manage cookies full article pdf apoptosis perspectives part merck research laboratories july 1995 volume 2 van de loo van de craen check access instant access european economic area cysteine protease family merck frosst centre pointe claire-dorval conditions privacy policy extremely attractive targets related proteases accepting optional cookies cysteine protease responsible x-ray crystallography journal finder publish programmed cell death interleukin-1 function article perspectives nicholson rights article log cpp32 therapeutic research article thornberry article cite privacy policy personal data books a inflammation van ness optional cookies manage preferences design nancy enzyme apoptosis subscription content similar content data protection essential cookies cookies skip institution subscribe

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Interleukin-1β-converting enzyme and related proteases as potential targets in inflammation and apoptosis
         description:Interleukin-1β-converting enzyme (ICE, EC 3.4.22.36) is the cysteine protease responsible for the production of interleukin-1β in monocytes. Since its discovery in 1989, this enzyme has been the subject of enthusiastic investigation because of the suspected role of this cytokine in the pathogenesis of inflammatory diseases such as rheumatoid arthritis. These studies have culminated in the purification and cloning of the enzyme, development of potent inhibitors, determination of its structure by X-ray crystallography and the development of knockout mice, which have confirmed an important role for this protease in inflammation. Late in 1993, the protease became the subject of further interest because of its homology to CED-3, the product of a gene required for programmed cell death in the nematodeC. elegans. It is now clear that ICE is the first identified member of a new cysteine protease family that includes CED-3 and at least four other human homologues. Although the extent to which ICE itself plays a role in mammalian apoptosis remains controversial, it is clear that at least one of these homologues, CPP32, is an important player. The recognition that members of this family play key biological roles in both inflammation and apoptosis, two extremely attractive targets for therapeutic intervention, has led to intense interest in these proteases.
         datePublished:
         dateModified:
         pageStart:389
         pageEnd:399
         sameAs:https://doi.org/10.1007/BF02172032
         keywords:
            Interleukin-1β-converting enzyme
            Inflammation
            Apopain
            CPP32
            Apoptosis
            Pharmacy
            Biotechnology
            Animal Anatomy / Morphology / Histology
            Biochemistry
            general
            Polymer Sciences
         image:
         isPartOf:
            name:Perspectives in Drug Discovery and Design
            issn:
               1573-9023
               0928-2866
            volumeNumber:2
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Nancy A. Thornberry
               affiliation:
                     name:Merck Research Laboratories, R80W-243
                     address:
                        name:Department of Enzymology, Merck Research Laboratories, R80W-243, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Douglas K. Miller
               affiliation:
                     name:Merck Research Laboratories, R80N-A32
                     address:
                        name:Department of Biochemical and Molecular Pathology, Merck Research Laboratories, R80N-A32, Rahway, U.S.A.
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Donald W. Nicholson
               affiliation:
                     name:Merck Frosst Centre for Therapeutic Research
                     address:
                        name:Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Interleukin-1β-converting enzyme and related proteases as potential targets in inflammation and apoptosis
      description:Interleukin-1β-converting enzyme (ICE, EC 3.4.22.36) is the cysteine protease responsible for the production of interleukin-1β in monocytes. Since its discovery in 1989, this enzyme has been the subject of enthusiastic investigation because of the suspected role of this cytokine in the pathogenesis of inflammatory diseases such as rheumatoid arthritis. These studies have culminated in the purification and cloning of the enzyme, development of potent inhibitors, determination of its structure by X-ray crystallography and the development of knockout mice, which have confirmed an important role for this protease in inflammation. Late in 1993, the protease became the subject of further interest because of its homology to CED-3, the product of a gene required for programmed cell death in the nematodeC. elegans. It is now clear that ICE is the first identified member of a new cysteine protease family that includes CED-3 and at least four other human homologues. Although the extent to which ICE itself plays a role in mammalian apoptosis remains controversial, it is clear that at least one of these homologues, CPP32, is an important player. The recognition that members of this family play key biological roles in both inflammation and apoptosis, two extremely attractive targets for therapeutic intervention, has led to intense interest in these proteases.
      datePublished:
      dateModified:
      pageStart:389
      pageEnd:399
      sameAs:https://doi.org/10.1007/BF02172032
      keywords:
         Interleukin-1β-converting enzyme
         Inflammation
         Apopain
         CPP32
         Apoptosis
         Pharmacy
         Biotechnology
         Animal Anatomy / Morphology / Histology
         Biochemistry
         general
         Polymer Sciences
      image:
      isPartOf:
         name:Perspectives in Drug Discovery and Design
         issn:
            1573-9023
            0928-2866
         volumeNumber:2
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Nancy A. Thornberry
            affiliation:
                  name:Merck Research Laboratories, R80W-243
                  address:
                     name:Department of Enzymology, Merck Research Laboratories, R80W-243, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Douglas K. Miller
            affiliation:
                  name:Merck Research Laboratories, R80N-A32
                  address:
                     name:Department of Biochemical and Molecular Pathology, Merck Research Laboratories, R80N-A32, Rahway, U.S.A.
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Donald W. Nicholson
            affiliation:
                  name:Merck Frosst Centre for Therapeutic Research
                  address:
                     name:Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Perspectives in Drug Discovery and Design
      issn:
         1573-9023
         0928-2866
      volumeNumber:2
Organization:
      name:Kluwer Academic Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Merck Research Laboratories, R80W-243
      address:
         name:Department of Enzymology, Merck Research Laboratories, R80W-243, USA
         type:PostalAddress
      name:Merck Research Laboratories, R80N-A32
      address:
         name:Department of Biochemical and Molecular Pathology, Merck Research Laboratories, R80N-A32, Rahway, U.S.A.
         type:PostalAddress
      name:Merck Frosst Centre for Therapeutic Research
      address:
         name:Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Canada
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Nancy A. Thornberry
      affiliation:
            name:Merck Research Laboratories, R80W-243
            address:
               name:Department of Enzymology, Merck Research Laboratories, R80W-243, USA
               type:PostalAddress
            type:Organization
      name:Douglas K. Miller
      affiliation:
            name:Merck Research Laboratories, R80N-A32
            address:
               name:Department of Biochemical and Molecular Pathology, Merck Research Laboratories, R80N-A32, Rahway, U.S.A.
               type:PostalAddress
            type:Organization
      name:Donald W. Nicholson
      affiliation:
            name:Merck Frosst Centre for Therapeutic Research
            address:
               name:Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Canada
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Enzymology, Merck Research Laboratories, R80W-243, USA
      name:Department of Biochemical and Molecular Pathology, Merck Research Laboratories, R80N-A32, Rahway, U.S.A.
      name:Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Canada
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(97)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.61s.

LINK . SPRINGER . COM {}